Latest Leadership Changes News

Papyrus Australia has taken a major step towards commercialisation by signing a $4.2 million binding Terms Sheet with TBS Mining Solutions and progressing a high-volume production facility in Vietnam. The company also secured a $250,000 government grant and restructured its leadership to support growth.

Dundas Minerals advances its gold exploration with AI-driven targeting at the vast Gerry Well Greenstone Belt, appoints new Managing Director Jonathan Downes, and secures $1.12 million in fresh funding.

Kaiser Reef reports record gold production at Henty, extends mine life beyond six years, and advances exploration at Maldon, while transitioning A1 mine to care and maintenance.

COSOL Limited reports a $7-8 million revenue shortfall in H1 FY26 amid macroeconomic pressures but pivots towards higher-margin Asset Management as a Service contracts and cost efficiencies to stabilize performance.

Althea Group Holdings reported a resilient September quarter with $5.4 million in receipts despite a major strike in British Columbia, bolstered by a $2.53 million capital raise and expansion in the US THC beverage market.

Patrys Limited has raised $1.77 million through a fully underwritten entitlement offer to fund preclinical studies and business development for its deoxymab therapeutic antibodies. The company also completed a capital consolidation and held a successful AGM, signaling a strategic pivot into immunology and inflammation.

Karoon Energy has appointed industry veteran Carri Lockhart as its new CEO, signaling a strategic push as it prepares to operate the Baúna FPSO and expand in Brazil and the US.

Future Generation announces CEO Caroline Gurney will step down in early 2026, leaving behind a legacy of strong investment returns and $100 million donated to Australian non-profits. An executive search is underway to find her successor.

Future Metals NL appoints Keith Bowes as CEO and initiates a strategic review of its flagship Panton project, leveraging rising platinum group metal prices and exploration successes. The company also completes a A$4.2 million capital raise and plans to delist from AIM.

Arovella Therapeutics reported solid progress in Q1 FY26, moving closer to initiating its first-in-human trial for ALA-101 while securing key patents and maintaining a strong cash position.

Locksley Resources appoints Kerrie Matthews as Managing Director and CEO to spearhead the commercialisation of U.S.-produced antimony, following a landmark domestic metal ingot milestone.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.